Hypoglycemia, Hyperglycemia and Astaxanthin: An <i>in Vitro</i> Alzheimer’s Disease Model

ISSN Print: 2169-2459
ISSN Online: 2169-2467
www.scirp.net/journal/aad
E-mail: [email protected]

Citations

"Hypoglycemia, Hyperglycemia and Astaxanthin: An in Vitro Alzheimer’s Disease Model"
written by Julie Griffith, Shauna Northup, Emma Cieslik, Marie Kelly-Worden,
published by Advances in Alzheimer's Disease, Vol.8 No.3, 2019

has been cited by the following article(s):

[1]	Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights
	Nasab, N Tanideh, A Iraji - Brain Research Bulletin, 2022

[2]	Simultaneous preconcentration and fluorescence detection of ATP by a hybrid nanocomposite of magnetic nanoparticles incorporated in mixed metal hydroxide
	Analytical Methods, 2022

[1]	Astaxanthin as an adjunct therapy in Alzheimer’s disease and multiple sclerosis: neuroprotective mechanisms and future perspective Nutritional Neuroscience, 2025 DOI:10.1080/1028415X.2025.2516620

[2]	Effect of dietary inclusion of artichoke (Cynara scolymus) leaf powder and astaxanthin on productive performance, hematological and biochemical profiles, hepatic and antioxidant enzyme activities, and gut microbiota in broiler chickens PLOS One, 2025 DOI:10.1371/journal.pone.0328784

[3]	Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights Brain Research Bulletin, 2023 DOI:10.1016/j.brainresbull.2022.11.018

[4]	Simultaneous preconcentration and fluorescence detection of ATP by a hybrid nanocomposite of magnetic nanoparticles incorporated in mixed metal hydroxide Analytical Methods, 2022 DOI:10.1039/D1AY01593A

[5]	Developing a City Brand Journal of Intercultural Management, 2019 DOI:10.2478/joim-2019-0022